dexmedetomidine has been researched along with Depression, Involutional in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Alawi, M; Brietzke, E; Carvalhal, A; Soares, CN | 1 |
| Al Anany, R; Elshafei, M; Gazwi, K; Mahmoud, S; Mohamed, A; Saad, MO | 1 |
| Briggs, MC; Bryson, EO; Kellner, CH; Pasculli, RM | 1 |
| Cohen, MB; Stewart, JT | 1 |
| Benefield, L; Gao, X; Gu, SL; Li, M; Ma, TF; Qin, SJ; Shen, QF; Villarreal, M; Wang, Y; Zhou, L; Zhuang, FZ | 1 |
| Bulut, M; Ganidagli, S; Koruk, S; Mizrak, A; Oner, U | 1 |
1 review(s) available for dexmedetomidine and Depression, Involutional
| Article | Year |
|---|---|
The potential anti-depressant properties of dexmedetomidine infusion: a review of mechanistic, preclinical, and clinical evidence.
Topics: Antidepressive Agents; Depression; Depressive Disorder, Major; Dexmedetomidine; Drug Resistance; Humans; Signal Transduction | 2020 |
1 trial(s) available for dexmedetomidine and Depression, Involutional
| Article | Year |
|---|---|
Premedication with dexmedetomidine and midazolam attenuates agitation after electroconvulsive therapy.
Topics: Adult; Anesthesia; Bipolar Disorder; Blood Pressure; Depressive Disorder, Major; Dexmedetomidine; Electroconvulsive Therapy; Female; Heart Rate; Humans; Hypnotics and Sedatives; Male; Midazolam; Premedication; Propofol; Psychomotor Agitation; Respiratory Insufficiency; Seizures | 2009 |
4 other study(ies) available for dexmedetomidine and Depression, Involutional
| Article | Year |
|---|---|
Effectivness of Clonidine in Treating Dexmedetomidine Withdrawal in a Patient with Co-Existing Psychiatric Illness: A Case Report.
Topics: Adult; Central Nervous System Agents; Clonidine; Depressive Disorder, Major; Dexmedetomidine; Female; Humans; Hypnotics and Sedatives; Meningitis, Viral; Substance Withdrawal Syndrome | 2018 |
Treatment-resistant postictal agitation after electroconvulsive therapy (ECT) controlled with dexmedetomidine.
Topics: Adrenergic alpha-Agonists; Aged; Anesthesia; Depressive Disorder, Major; Dexmedetomidine; Drug Resistance; Electroconvulsive Therapy; Female; Humans; Hypnotics and Sedatives; Psychomotor Agitation | 2013 |
Treatment of post-electroconvulsive therapy agitation with dexmedetomidine.
Topics: Aged; Depressive Disorder, Major; Dexmedetomidine; Electroconvulsive Therapy; Humans; Hypnotics and Sedatives; Male; Midazolam; Propofol; Psychomotor Agitation | 2013 |
Dexmedetomidine protects against learning and memory impairments caused by electroconvulsive shock in depressed rats: Involvement of the NMDA receptor subunit 2B (NR2B)-ERK signaling pathway.
Topics: Animals; Depressive Disorder, Major; Dexmedetomidine; Electroshock; Hippocampus; Hypnotics and Sedatives; Learning; Male; MAP Kinase Signaling System; Memory Disorders; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Treatment Outcome | 2016 |